BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

667 related articles for article (PubMed ID: 34588777)

  • 1. Ten Years of Knowledge of Nano-Carrier Based Drug Delivery Systems in Ophthalmology: Current Evidence, Challenges, and Future Prospective.
    Zhang J; Jiao J; Niu M; Gao X; Zhang G; Yu H; Yang X; Liu L
    Int J Nanomedicine; 2021; 16():6497-6530. PubMed ID: 34588777
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Nano-ophthalmology: Applications and considerations.
    Kamaleddin MA
    Nanomedicine; 2017 May; 13(4):1459-1472. PubMed ID: 28232288
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Nanotechnology in ocular delivery: current and future directions.
    Sultana Y; Maurya DP; Iqbal Z; Aqil M
    Drugs Today (Barc); 2011 Jun; 47(6):441-55. PubMed ID: 21695286
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Niosomal Drug Delivery Systems for Ocular Disease-Recent Advances and Future Prospects.
    Durak S; Esmaeili Rad M; Alp Yetisgin A; Eda Sutova H; Kutlu O; Cetinel S; Zarrabi A
    Nanomaterials (Basel); 2020 Jun; 10(6):. PubMed ID: 32570885
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A Mini-review on New Developments in Nanocarriers and Polymers for Ophthalmic Drug Delivery Strategies.
    Sharma Y; Patel P; Kurmi BD
    Curr Drug Deliv; 2024; 21(4):488-508. PubMed ID: 37143264
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Nano-Based Drug Delivery System: Recent Strategies for the Treatment of Ocular Disease and Future Perspective.
    Qamar Z; Qizilbash FF; Iqubal MK; Ali A; Narang JK; Ali J; Baboota S
    Recent Pat Drug Deliv Formul; 2019; 13(4):246-254. PubMed ID: 31884933
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Advancements in Nanosystems for Ocular Drug Delivery: A Focus on Pediatric Retinoblastoma.
    Wu KY; Wang XC; Anderson M; Tran SD
    Molecules; 2024 May; 29(10):. PubMed ID: 38792122
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Nano-antimicrobials: A New Paradigm for Combating Mycobacterial Resistance.
    Minakshi P; Ghosh M; Brar B; Kumar R; Lambe UP; Ranjan K; Manoj J; Prasad G
    Curr Pharm Des; 2019; 25(13):1554-1579. PubMed ID: 31218956
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Smart nano-micro platforms for ophthalmological applications: The state-of-the-art and future perspectives.
    Lyu Q; Peng L; Hong X; Fan T; Li J; Cui Y; Zhang H; Zhao J
    Biomaterials; 2021 Mar; 270():120682. PubMed ID: 33529961
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Nanotechnology in ocular drug delivery.
    Sahoo SK; Dilnawaz F; Krishnakumar S
    Drug Discov Today; 2008 Feb; 13(3-4):144-51. PubMed ID: 18275912
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Overview of Recent Advances in Nano-Based Ocular Drug Delivery.
    Liu LC; Chen YH; Lu DW
    Int J Mol Sci; 2023 Oct; 24(20):. PubMed ID: 37895032
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Recent Trends in Clinical Trials Related to Carrier-Based Drugs.
    Tagami T; Ozeki T
    J Pharm Sci; 2017 Sep; 106(9):2219-2226. PubMed ID: 28259767
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Nanoparticles as drug delivery systems in ophthalmology].
    Löscher M; Hurst J; Strudel L; Spitzer MS; Schnichels S
    Ophthalmologe; 2018 Mar; 115(3):184-189. PubMed ID: 29110121
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The Role of Nano-ophthalmology in Treating Dry Eye Disease.
    Natesan S; Boddu SHS; Krishnaswami V; Shahwan M
    Pharm Nanotechnol; 2020; 8(4):258-289. PubMed ID: 32600244
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Fundamentals, challenges, and nanomedicine-based solutions for ocular diseases.
    Srinivasarao DA; Lohiya G; Katti DS
    Wiley Interdiscip Rev Nanomed Nanobiotechnol; 2019 Jul; 11(4):e1548. PubMed ID: 30506871
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Nanocarriers in ocular drug delivery: an update review.
    Wadhwa S; Paliwal R; Paliwal SR; Vyas SP
    Curr Pharm Des; 2009; 15(23):2724-50. PubMed ID: 19689343
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Herbal nanomedicines: Recent advancements, challenges, opportunities and regulatory overview.
    Teja PK; Mithiya J; Kate AS; Bairwa K; Chauthe SK
    Phytomedicine; 2022 Feb; 96():153890. PubMed ID: 35026510
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Nano carriers for drug transport across the blood-brain barrier.
    Li X; Tsibouklis J; Weng T; Zhang B; Yin G; Feng G; Cui Y; Savina IN; Mikhalovska LI; Sandeman SR; Howel CA; Mikhalovsky SV
    J Drug Target; 2017 Jan; 25(1):17-28. PubMed ID: 27126681
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Nano-based drug delivery system for therapeutics: a comprehensive review.
    Prakash S
    Biomed Phys Eng Express; 2023 Aug; 9(5):. PubMed ID: 37549657
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Nanoformulations and Highlights of Clinical Studies for Ocular Drug Delivery Systems: An Overview.
    Momin MM; Afreen SD
    Crit Rev Ther Drug Carrier Syst; 2021; 38(4):79-107. PubMed ID: 34369740
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 34.